摘要:
Novel cephalosporin derivatives and physiologically acceptable salts thereof which are useful as antibacterial agents against gram-negative and gram-positive bacteria, and a process for preparing these compounds are disclosed.
摘要:
Pyrido[1,2,3-de] [1,4]benzoxazine derivatives are described having the formula (1) wherein X is a halogen atom, R is a hydrogen atom or an alkyl group of 1 to 6 carbon atoms and Z represents mono-substituted, di-substituted or cyclic-substituted amino group which may contain a hetero atom and may have a substituent such as hydroxy, alkyl having 1 to 6 carbon atoms, amino, hydroxyalkyl having 1 to 6 carbon atoms or mono- or di-alkylamino having 1 to 6 carbon atoms in each alkyl moiety and the pharmaceutically acceptable salt thereof, having antibacterial activity.
摘要:
Process for producing 4-aminomethylbicyclo (2,2,2)octane-1-carboxylic acid and intermediate therefor 4-aminomethylbicyclo(2,2,2)octane-1-carboxylic acid or a pharmaceutically acceptable salt thereof is prepared by reacting a compound of the formula: (wherein R is a hydrogen atom or a lower alkyl group) with ethylene, under a pressure of 60 to 300 kg/cm 2 at a temperature of 100°-250°C. to produce a 4-cyanobicyclo(2,2,2,)oct-2-en-1-carboxylic acid of the formula: (wherein R is the same as defined above), catalytically reducing the bicyclo compound and hydrolyzing the reduction product.
摘要:
Medicinal compositions, which quickly disintegrate after putting into the oral cavity and exert a hardness sufficient for the common production, distribution and utilization procedures, are prepared by adding, to sugar alcohols or sugars, sugar alcohols or sugars having lower melting points, and then subjecting the resultant mixture to compression and heating. Thus, medicinal compositions, which quickly disintegrate after putting into the oral cavity without resort to water and are excellent in handling properties because of having a hardness sufficient for the common production, distribution and utilization procedures, can be provided. Moreover, it is possible to provide a process for more conveniently producing a medicinal composition whereby the contact of a drug component with moisture can be avoided, if needed.
摘要:
A compound represented by the general formula (I), a salt of the compound, or a solvate of either; a medicine containing any of these; an agent for the prevention of and/or treatments for ischemic diseases which contains any of these; and a platelet aggregation inhibitor containing any of these. The compound is useful as a potent platelet aggregation inhibitor which inhibits neither COX-1 nor COX-2.
摘要:
A medicine for prevention and/or therapy of a microbe infectious disease, which comprises, as an active component, a compound represented by the following formula (1): (1) wherein R1 and R2 each represent hydrogen, a halogen atom, a hydroxyl group or the like; W1 represents -CH=CH-, -CH2O-, -CH2 CH2- or the like; R3 represents hydrogen, a halogen atom, a hydroxyl group or an amino group; R4 represents hydrogen, a group of -OZ0-4R5 (where Z0-4 represents an alkylene group or a fluorine-substituted alkylene group or a single bond and R5 represents a cyclic alkyl group, an aryl group or the like) or the like; W2 represents a single bond or -C(R8)=C(R9)- (where R8 and R9 each represent hydrogen, a halogen atom, a lower alkyl group or the like) and Q represents an acidic group, with the proviso that W2 and Q may together form a heterocyclic ring of vinylidene thiazolidinedione or an equivqlent thereof; m and n each represent an integer of 0 to 2 and q represents an integer of 0 to 3.
摘要:
Disclosed is a method for producing a halogenated unsaturated carbonyl compound commercially advantageously without causing environmental problems. A method for producing a halogenated unsaturated carbonyl compound represented by the general formula (III) below is characterized in that an alkoxy cyclic ether represented by the general formula (I) below is reacted with an acid halide represented by the general formula (II) below. (In the above formulae, symbols are as defined in the description.)